SAB Biotherapeutics stock price
NASDAQ:SABS · Nasdaq · Healthcare · sector #16SAB Biotherapeutics's chart data is dated 2026-10-21. Recorded technical signals: MACD bullish cross, Mean reversion. The display ticker is SABS.
SAB Biotherapeutics last closed at $2.82 (-2.08%) on 2026-10-21. Signals today: MACD bullish cross, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -17.6×. Its overall grade ranks 339 of 727 stocks in Healthcare.
About this company
SAB Biotherapeutics last closed at $2.82 (-2.08%) on 2026-10-21. Signals today: MACD bullish cross, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B · 339/727
Valuation grade A
About SAB Biotherapeutics
- What technical signals does SAB Biotherapeutics (SABS) have?
- SAB Biotherapeutics current technical signals: MACD bullish cross, Mean reversion.
- Is SAB Biotherapeutics a cup-and-handle pattern?
- No. SAB Biotherapeutics has no valid Cup signal right now.
- What published figures are available for SAB Biotherapeutics?
- Market cap: $134.25M. Trailing 12 months PER: -17.6×. Latest quarter PBR: 1.05×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about SAB Biotherapeutics, or open the plan table on the main site.
Ask Q about SAB Biotherapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.